{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:38:32Z","timestamp":1778686712732,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007289","name":"Nanjing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.bbrc.2019.07.061","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T17:25:43Z","timestamp":1564593943000},"page":"532-537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effects of miR-150 on neuropathic pain process via targeting AKT3"],"prefix":"10.1016","volume":"517","author":[{"given":"Wei","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1293-7012","authenticated-orcid":false,"given":"Zhen","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbrc.2019.07.061_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/papr.12085","article-title":"Neuropathic pain and pharmacological treatment","volume":"14","author":"Jongen","year":"2014","journal-title":"Pain Pract."},{"key":"10.1016\/j.bbrc.2019.07.061_bib2","doi-asserted-by":"crossref","first-page":"f7656","DOI":"10.1136\/bmj.f7656","article-title":"Neuropathic pain: mechanisms and their clinical implications","volume":"348","author":"Cohen","year":"2014","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.bbrc.2019.07.061_bib3","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"van Hecke","year":"2014","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.bbrc.2019.07.061_bib4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2174\/1389200216666151015113400","article-title":"Emerging role of microRNA in neuropathic pain","volume":"17","author":"Jiangpan","year":"2016","journal-title":"Curr. Drug Metabol."},{"issue":"1","key":"10.1016\/j.bbrc.2019.07.061_bib5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11064-013-1192-z","article-title":"Intrathecal miR-96 inhibits Nav1.3 expression and alleviates neuropathic pain in rat following chronic construction injury","volume":"39","author":"Chen","year":"2014","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.bbrc.2019.07.061_bib6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/glia.22451","article-title":"Increased miR-195 aggravates neuropathic pain by inhibiting autophagy following peripheral nerve injury","volume":"61","author":"Shi","year":"2013","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.bbrc.2019.07.061_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000455987","article-title":"MicroRNA-183 suppresses neuropathic pain and expression of AMPA receptors by targeting mTOR\/VEGF signaling pathway","volume":"41","author":"Xie","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.bbrc.2019.07.061_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1582-4934.2005.tb00337.x","article-title":"The activation of Akt\/PKB signaling pathway and cell survival","volume":"9","author":"Song","year":"2005","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.bbrc.2019.07.061_bib9","series-title":"Increased Activities of Akt in Psoriatic Epidermis","author":"Zhang","year":"2009"},{"issue":"21","key":"10.1016\/j.bbrc.2019.07.061_bib10","first-page":"4853","article-title":"MiR-150 alleviates EMT and cell invasion of colorectal cancer through targeting Gli1","volume":"21","author":"Fan","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.bbrc.2019.07.061_bib11","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1111\/jcmm.13201","article-title":"miR-181a and miR-150 regulate dendritic cell immune inflammatory responses and cardiomyocyte apoptosis via targeting JAK1-STAT1\/c-Fos pathway","volume":"21","author":"Zhu","year":"2017","journal-title":"J.\u00a0Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2019.07.061_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A\u00a0peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.bbrc.2019.07.061_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/ALN.0000000000000265","article-title":"Noncoding RNAs: new players in chronic pain","volume":"121","author":"Lutz","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bbrc.2019.07.061_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-3-319-22671-2_3","article-title":"microRNA and Pain","volume":"888","author":"Sakai","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbrc.2019.07.061_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fnmol.2017.00091","article-title":"Identification of the spinal expression profile of non-coding RNAs involved in neuropathic pain following spared nerve injury by sequence analysis","volume":"10","author":"Zhou","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"10","key":"10.1016\/j.bbrc.2019.07.061_bib16","doi-asserted-by":"crossref","first-page":"8555","DOI":"10.1002\/jcb.27096","article-title":"MiR-28-5p relieves neuropathic pain by targeting Zeb1 in CCI rat models","volume":"119","author":"Bao","year":"2018","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.bbrc.2019.07.061_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuroscience.2018.12.030","article-title":"MiR-34c ameliorates neuropathic pain by targeting NLRP3 in a mouse model of chronic constriction injury","volume":"399","author":"Xu","year":"2019","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.bbrc.2019.07.061_bib18","doi-asserted-by":"crossref","first-page":"10363","DOI":"10.1002\/jcb.28320","article-title":"miR-98 acts as an inhibitor in chronic constriction injury-induced neuropathic pain via downregulation of high-mobility group AT-hook 2","volume":"120","author":"Zhang","year":"2019","journal-title":"J.\u00a0Cell. Biochem."},{"issue":"8","key":"10.1016\/j.bbrc.2019.07.061_bib19","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1002\/jcp.26453","article-title":"XIST accelerates neuropathic pain progression through regulation of miR-150 and ZEB1 in CCI rat models","volume":"233","author":"Yan","year":"2018","journal-title":"J.\u00a0Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bbrc.2019.07.061_bib20","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/jcb.26269","article-title":"MiR-150 alleviates neuropathic pain via inhibiting toll-like receptor 5","volume":"119","author":"Ji","year":"2018","journal-title":"J.\u00a0Cell. Biochem."},{"issue":"7","key":"10.1016\/j.bbrc.2019.07.061_bib21","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1089\/thy.2010.1646","article-title":"Genetic alterations in the phosphatidylinositol-3 kinase\/Akt pathway in thyroid cancer","volume":"20","author":"Xing","year":"2010","journal-title":"Thyroid"},{"issue":"7152","key":"10.1016\/j.bbrc.2019.07.061_bib22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature05933","article-title":"A\u00a0transforming mutation in the pleckstrin homology domain of AKT1 in cancer","volume":"448","author":"Carpten","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbrc.2019.07.061_bib23","first-page":"196","article-title":"Overexpression of AKT2\/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells","volume":"63","author":"Arboleda","year":"2003","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.bbrc.2019.07.061_bib24","first-page":"2172","article-title":"The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines","volume":"63","author":"Grille","year":"2003","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bbrc.2019.07.061_bib25","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1158\/0008-5472.CAN-06-1479","article-title":"Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel","volume":"67","author":"Cheng","year":"2007","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bbrc.2019.07.061_bib26","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1073\/pnas.1414573112","article-title":"Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression","volume":"112","author":"Turner","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.bbrc.2019.07.061_bib27","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41419-019-1637-7","article-title":"A\u00a0novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3","volume":"10","author":"Feng","year":"2019","journal-title":"Cell Death Dis."},{"issue":"18","key":"10.1016\/j.bbrc.2019.07.061_bib28","first-page":"5972","article-title":"MicroRNA-217 alleviates development of non-small cell lung cancer by inhibiting AKT3 via PI3K pathway","volume":"22","author":"Qi","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"22","key":"10.1016\/j.bbrc.2019.07.061_bib29","first-page":"5112","article-title":"MicroRNA-582-5p suppressed gastric cancer cell proliferation via targeting AKT3","volume":"21","author":"Jin","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.bbrc.2019.07.061_bib30","first-page":"1177","article-title":"MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3","volume":"7","author":"Sui","year":"2017","journal-title":"Am J Cancer Res"},{"issue":"3","key":"10.1016\/j.bbrc.2019.07.061_bib31","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1158\/0008-5472.CAN-13-2175","article-title":"Targeting Akt3 signaling in triple-negative breast cancer","volume":"74","author":"Chin","year":"2014","journal-title":"Cancer Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19314159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19314159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:38:52Z","timestamp":1757763532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X19314159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0006291X19314159"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.07.061","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of miR-150 on neuropathic pain process via targeting AKT3","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.07.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}